National Cancer Central Hospital
Chūōku 104-0045
0 studies enrolling now · 1 studies all time
What they study most
Non-Small Cell Lung Cancer
Studies at this site
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
— Completed